The War Is Coming to an End. A Novel COVID-19 Vaccine Shows Promising Results

Oxford University researchers managed to create an experimental vaccine which is showing promising results against the novel COVID-19. Six monkeys underwent several tests to identify the inner workings of this promising medicine. ChAdOx1 nCoV-19, the potential cure for coronavirus, is currently being tested on humans as well. Approximately 1,000 patients decided to volunteer for clinical trials.

The conclusions of the study conducted on the sic monkeys, part of the rhesus macaque breed, were published on the 14th of May on bioRxiv. What is even more interesting is that these monkeys are highly renowned for their similar immune system to the human system. However, it is still not 100% certain that the results apply to humans.

The study shows that those monkeys who were infected with the novel coronavirus and not treated developed more infections to their lungs. In the meantime, the monkeys that were injected were less susceptible to severe complications, developing fewer infections in their lungs. Therefore, this vaccine is an impressive result that aims to prevent the severe complications of SARS-CoV-2 in rhesus macaques.

The trial was conducted in the United States of America by several researchers from Oxford University and the National Institutes of Health in the US. Oxford University has decided after receiving positive results to carry on with testing this medicine on humans as well and are currently waiting to collect the necessary data.

Initially, the composition of this vaccine was developed by Oxford’s Jenner Institute and the Oxford Vaccine Group. The main “ingredients” include the spike protein structure of COVID-19 and the adenovirus vaccine vector.

This vaccine aims to help the body recognize this virus and build its strong immune response against the Spike protein from infecting the body. Therefore, the researchers developed a product that seeks to prevent the human body from getting infected with this virus.

At the moment, 100 experimental COVID-19 vaccines undergo various stages of development all over the world.

This article was originally published on